COEP Coeptis Therapeutics Holdings Inc
Price (delayed)
$9.48
Market cap
$31.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.65
Enterprise value
$32.77M
Highlights
The EPS has soared by 66% YoY
Coeptis Therapeutics Holdings's debt has decreased by 21% from the previous quarter but it has increased by 14% YoY
The quick ratio has dropped by 76% year-on-year and by 64% since the previous quarter
The equity is down by 34% since the previous quarter
Key stats
What are the main financial stats of COEP
Market
Valuations
Earnings
Shares outstanding
3.36M
Market cap
$31.9M
Enterprise value
$32.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.12
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$10.05M
Net income
-$9.81M
EBIT
-$9.42M
EBITDA
-$8.38M
Free cash flow
-$6.65M
Per share
Balance sheet
Liquidity
EPS
-$5.65
EPS diluted
-$5.65
Free cash flow per share
-$3.45
Book value per share
$1.55
Revenue per share
$0
TBVPS
$4.35
Total assets
$8.91M
Total liabilities
$5.04M
Debt
$1.4M
Equity
$3.19M
Working capital
-$3.46M
Debt to equity
0.44
Current ratio
0.23
Quick ratio
0.12
Net debt/EBITDA
-0.1
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-151.2%
Return on equity
-610.8%
Return on invested capital
-297.4%
Return on capital employed
-214.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
COEP stock price
How has the Coeptis Therapeutics Holdings stock price performed over time
Intraday
0.11%
1 week
0.74%
1 month
-11.81%
1 year
50.72%
YTD
72.36%
QTD
1.17%
Financial performance
How have Coeptis Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.05M
Net income
-$9.81M
Gross margin
N/A
Net margin
N/A
Coeptis Therapeutics Holdings's operating income has soared by 53% YoY and by 11% from the previous quarter
Growth
What is Coeptis Therapeutics Holdings's growth rate over time
Valuation
What is Coeptis Therapeutics Holdings stock price valuation
P/E
N/A
P/B
6.12
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 66% YoY
The equity is down by 34% since the previous quarter
Efficiency
How efficient is Coeptis Therapeutics Holdings business performance
COEP's return on assets has dropped by 185% since the previous quarter
Coeptis Therapeutics Holdings's return on invested capital has shrunk by 169% QoQ
The company's return on equity has shrunk by 164% QoQ
Dividends
What is COEP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for COEP.
Financial health
How did Coeptis Therapeutics Holdings financials performed over time
The total assets is 77% greater than the total liabilities
The total assets has surged by 95% year-on-year
The quick ratio has dropped by 76% year-on-year and by 64% since the previous quarter
Coeptis Therapeutics Holdings's debt is 56% less than its equity
COEP's debt to equity has dropped by 71% year-on-year but it is up by 19% since the previous quarter
The equity is down by 34% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.